General form of registration statement for all companies including face-amount certificate companies

Stockholders' Equity - Additional Information (Details)

v3.23.1
Stockholders' Equity - Additional Information (Details) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended
Aug. 03, 2022
Aug. 01, 2022
Aug. 13, 2021
May 31, 2022
Jan. 31, 2022
Feb. 28, 2022
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Subsidiary Or Equity Method Investee [Line Items]                    
Common stock, shares authorized   70,000,000           70,000,000 30,000,000  
Preferred stock, shares authorized   30,000,000           30,000,000 70,000,000  
Number of common stock sold       11,111   263,729        
Sale of common stock, price per share       $ 9   $ 9        
Proceeds from issuance of common stock, net of transaction costs $ 9,100,000     $ 99,999   $ 2,373,561   $ 2,473,560 $ 5,742,171  
Transaction costs       $ 0   $ 0        
Stock price per share           $ 9.00       $ 8.00
Common stock, shares issued               10,955,904 7,584,980  
Deemed dividend on warrant modification               $ (450,578)    
Warrants exercised, shares       394,501            
Cashless exercise at fair market value per share       $ 9.00            
Issuance of common shares in connection with initial public offering, net of $2,749,905 issuance cost       315,601            
Warrants exercise price, per share   $ 6.25               $ 6.00
Warrants and rights exercisable period   Jan. 23, 2023                
Class of warrant or right date from which warrants or rights expire   Jul. 27, 2027                
Warrant liability               $ 245,341 $ 0  
Fair value assumptions, contractual term               7 years    
Change in fair value of warrant liability               $ (98,394) $ 1,546,280  
Warrants issued               115,000    
Stock options outstanding               6,545,628 5,797,185  
Percentage of shares granted               10.00%    
Exercise price percentage               110.00%    
Common stock, par value               $ 0.0001 $ 0.0001  
2018 Stock Option Plan                    
Subsidiary Or Equity Method Investee [Line Items]                    
Stock options outstanding               1,924,500    
Amended and Restated 2020 Equity Incentive Plan                    
Subsidiary Or Equity Method Investee [Line Items]                    
Stock options outstanding               3,983,023    
Common stock reserved for issuance               0    
2021 Equity Incentive Plan                    
Subsidiary Or Equity Method Investee [Line Items]                    
Stock options outstanding               638,105    
Common stock reserved for issuance   1,909,518           1,271,413    
Black-Sholes Method                    
Subsidiary Or Equity Method Investee [Line Items]                    
Warrant liability $ 343,735                  
Fair value assumptions, contractual term 5 years                  
Risk free interest rate 2.82%                  
Volatility rate 77.50%                  
Change in fair value of warrant liability               $ 98,394    
Maximum                    
Subsidiary Or Equity Method Investee [Line Items]                    
Warrants to purchase common stock   100,000                
Fair value assumptions, contractual term               10 years    
Founder                    
Subsidiary Or Equity Method Investee [Line Items]                    
Stock compensation expense                 $ 202,500  
Issuance of restricted common shares, Shares                 87,500  
Restricted Stock Awards                    
Subsidiary Or Equity Method Investee [Line Items]                    
Unvested shares               0 58,333  
Restricted Stock Awards | Founder                    
Subsidiary Or Equity Method Investee [Line Items]                    
Shares granted                 112,500  
Unrecognized compensation                 $ 52,500  
Warrant                    
Subsidiary Or Equity Method Investee [Line Items]                    
Warrant modification, value         $ 144,497          
Deemed dividend on warrant modification             $ 450,578      
Warrant | Maximum                    
Subsidiary Or Equity Method Investee [Line Items]                    
Fair value assumptions, contractual term               5 years 7 years  
Warrant | Minimum [Member]                    
Subsidiary Or Equity Method Investee [Line Items]                    
Fair value assumptions, contractual term               4 years 7 months 6 days 5 years  
Share-Based Payment Arrangement, Option                    
Subsidiary Or Equity Method Investee [Line Items]                    
Unrecognized compensation               $ 3,447,367    
Weighted-average grant date fair value               $ 3.75 $ 3.55  
Unrecognized compensation expense, recognized period               3 years 3 months 3 days    
Share-Based Payment Arrangement, Option | Maximum                    
Subsidiary Or Equity Method Investee [Line Items]                    
Fair value assumptions, contractual term               6 years 3 months 6 years 6 months  
Share-Based Payment Arrangement, Option | Minimum [Member]                    
Subsidiary Or Equity Method Investee [Line Items]                    
Fair value assumptions, contractual term               5 years 5 years  
THIO | Founder                    
Subsidiary Or Equity Method Investee [Line Items]                    
Issuance of restricted common shares, Shares     612,500              
THIO | Restricted Stock Awards | Founder                    
Subsidiary Or Equity Method Investee [Line Items]                    
Founders shares cancelled     612,500              
IPO                    
Subsidiary Or Equity Method Investee [Line Items]                    
Number of common stock sold   2,000,000                
Sale of common stock, price per share   $ 5                
Stock price per share   $ 5.00       $ 5.00        
Common stock, shares issued   219,872                
Stock Issued During Period, Value, New Issues   $ 1,099,360                
Gross proceeds from common stock   $ 10,000,000                
Number of warrants exercised   20,520                
Warrants exercise price, per share   $ 5.00                
Over-Allotment Option                    
Subsidiary Or Equity Method Investee [Line Items]                    
Number of common stock sold 300,000                  
Sale of common stock, price per share $ 5                  
Stock price per share $ 5.00                  
Gross proceeds from common stock $ 1,500,000                  
Over-Allotment Option | Maximum                    
Subsidiary Or Equity Method Investee [Line Items]                    
Class of warrant or right additional purchase aggregate of common stock 15,000                  
Common Stock                    
Subsidiary Or Equity Method Investee [Line Items]                    
Number of common stock sold       11,111   263,729        
Sale of common stock, price per share       $ 9   $ 9.00        
Issuance of restricted common shares, Shares                 15,278  
Issuance of common shares upon exercise of warrants, Shares       153,000 61,111     529,712 283,616  
Proceeds from issuance of common stock upon exercise of warrants       $ 275,400 $ 110,000          
Issuance of common shares in connection with initial public offering, net of $2,749,905 issuance cost               2,300,000    
Common Stock | Maximum                    
Subsidiary Or Equity Method Investee [Line Items]                    
Sale of common stock, price per share               $ 8.87    
Common Stock | January Twenty Seven To May Thirty One Two Thousand Twenty Two                    
Subsidiary Or Equity Method Investee [Line Items]                    
Common stock, par value               9    
Common Stock | June One Two Thousand Twenty Two To August One Two Thousand Twenty Two                    
Subsidiary Or Equity Method Investee [Line Items]                    
Common stock, par value               $ 5    
Common Stock | Maximum                    
Subsidiary Or Equity Method Investee [Line Items]                    
Sale of common stock, price per share                 $ 1.80  
Common Stock | March One Two Thousand Twenty One To June Six Two Thousand Twenty One                    
Subsidiary Or Equity Method Investee [Line Items]                    
Sale of common stock, price per share                 $ 1.83  
Warrant                    
Subsidiary Or Equity Method Investee [Line Items]                    
Warrant liability               $ 245,341